Aspartame bioassay findings portend human cancer hazards

The U.S. Food and Drug Administration (FDA) should reevaluate its position on aspartame as being safe under all conditions. Animal bioassay results predict human cancer risks, and a recent animal study confirms that there is a potential aspartame risk to humans. Aspartame is produced and packaged in...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of occupational and environmental health Vol. 13; no. 4; p. 446
Main Authors Huff, James, LaDou, Joseph
Format Journal Article
LanguageEnglish
Published England 01.10.2007
Subjects
Animals
Aspartame - adverse effects
Aspartame - standards
Biological Assay
Carcinogenicity Tests
Humans
Neoplasms - chemically induced
Occupational Exposure
Occupational Health
Sweetening Agents - adverse effects
Sweetening Agents - standards
United States
United States Food and Drug Administration - standards
United States
Online AccessGet more information

Cover

More Information
Summary:The U.S. Food and Drug Administration (FDA) should reevaluate its position on aspartame as being safe under all conditions. Animal bioassay results predict human cancer risks, and a recent animal study confirms that there is a potential aspartame risk to humans. Aspartame is produced and packaged in China for domestic use and global distribution. Japan, France, and the United States are also major producers. No study of long-term adverse occupational health effects on aspartame workers have been conducted. The FDA should consider sponsoring a prospective epidemiologic study of aspartame workers.
ISSN:1077-3525
2049-3967
DOI:10.1179/oeh.2007.13.4.446